Announcement
15 May 2020
In May 2020, the Norwegian authorities introduced an export ban on midazolam due to concerns of domestic shortages following the COVID-19 pandemic. In June 2020, the export ban was terminated.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
15 May 2020
Revocation date:
14 Jun 2020
On 15 May 2020, the Norwegian Medicines Agency introduced an export ban on midazolam. The export ban was introduced due to concerns of domestic shortages following the COVID-19 outbreak.
No...
See all
This state act is not part of any Thread yet.